imt - OmicsDI

Show results for

Unknown (1381)
Genomics (68)
Proteomics (15)
Transcriptomics (8)
Clinical (3)
Genomic (2)
Other (1)

Organisms

Andropogon gerardi (13)
Bacteria (13)
Canis lupus familiaris (13)
Chromatiales bacterium OalgGamma1 (13)
Clavibacter nebraskensis NCPPB 2581 (13)
Cnidaria (13)
Ensifer adhaerens (13)
Fasciola (13)
Human alphaherpesvirus 1 strain 17 (13)
Human alphaherpesvirus 1 strain KOS (13)
Human betaherpesvirus 5 (13)
Human herpesvirus 2 strain 186 (13)
Mesocricetus auratus (13)
Miscanthus x giganteus (13)
Mus musculus (13)
Panicum virgatum (13)
Platyhelminthes (13)
Pseudomonas aeruginosa PA103 (13)
Rattus norvegicus (13)
Rattus rattus (13)
Rhodococcus jostii RHA1 (13)
Rhodopseudomonas palustris (13)
Shigella (13)
Sorghastrum nutans (13)
Spirochaeta sp. ELBA (13)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (13)
Homo sapiens (11)
Solanum lycopersicum (4)
Mus musculus (2)
Sus scrofa (1)

Organisms

Homo sapiens (21)
Mus musculus (8)
uncultured bacterium (2)
retting metagenome (2)
Chryseobacterium sediminis (1)
Drosophila melanogaster (1)
gut metagenome (1)
Sus scrofa (1)
plant metagenome (1)
Escherichia coli (1)
human gut metagenome (1)

Repository

ENA (60)
pride (13)
geo (9)
EGA (7)
biostudies-arrayexpress (2)
dbGaP (2)
MassIVE (2)

Tissue

Ascites (1)
Blood serum (1)
Fibroblast (1)
Liver (1)
Macrophage (1)
Permanent cell line cell (1)
Sperm (1)
Testis (1)
Whole body (1)

Disease

The study population will include patients with (1)
Hematologic Neoplasms (1)
Squamous Cell Carcinoma of Head and Neck (1)
Cardiovascular system disease (1)
Malignant neoplasm of ovary (1)

Technology Type

Mass Spectrometry (13)
Shotgun proteomics (7)
Affinity purification coupled with mass spectrometry proteomics (5)
Bottom-up proteomics (1)
Data-dependent acquisition (1)

Instrument Platform

Orbitrap Exploris 480 (2)

Publication Date

2026 (6)
2024 (5)
2021 (3)
2023 (3)
2012 (2)
2020 (2)
2010 (1)
2025 (1)
2022 (1)
2019 (1)
2018 (1)

First Public Date

2024 (9)
2023 (8)
2018 (7)
2022 (6)
2019 (6)
2021 (5)
2017 (5)
2025 (4)
2014 (4)
2015 (2)
2013 (2)
2026 (1)
2020 (1)

Classification

bacteria (1)

Study status

Active, not recruiting (1)
Recruiting (1)
Not yet recruiting (1)

Study type

Interventional (3)
Transcription profiling by array (1)

Release Date

2025 (181)
2022 (157)
2023 (156)
2024 (148)
2021 (131)
2020 (109)
2018 (83)
2019 (75)
2017 (70)
2016 (50)
2015 (49)
2014 (38)
2013 (30)
2011 (30)
2012 (19)
2026 (16)
2010 (13)
2009 (8)
2008 (8)
2007 (5)
2006 (2)
2004 (2)
2000 (2)
2003 (1)

Lab affiliation

1Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, 3584 CH Utrecht, The Netherlands 2Netherlands Proteomics Center, Padualaan 8, 3584 CH Utrecht, The Netherlands (1)
Department of Cell Biology, Harvard Medical School (1)
Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, D-50931, Germany Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SE-17177, Sweden Max Planck Institute for Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 77 Stockholm, Sweden (1)
Insitute of Molecular Biology and Tumor Research (IMT) University Marburg, Germany (1)
Institut für Molekularbiologie und Tumorforschung (IMT) Biomedizinisches Forschungszentrum Philipps-Universität Marburg Hans-Meerwein-Straße 2 35043 Marburg (Germany) Phone: +49-(0)6421-28-66840 (1)
Institute of Molecular Biology and Tumor Research (IMT) Center for Tumor Biology and Immunology (ZTI) Philipps-Universität Marburg (1)
Institute of Molecular Biology and Tumor Research (IMT), Philipps University of Marburg, Marburg, 35043, Germany (1)
Institute of Molecular Biology and Tumor Research (IMT)Philipps University of Marburg, Marburg, 35043, Germany and Department of Hematology, Oncology, and Immunology, University Hospital Giessen and Marburg, Marburg, 35043, Germany (1)
Institute of Molecular Biology and Tumor Research (IMT)Philipps University of Marburg, Marburg, 35043, Germany and Department of Hematology, Oncology, and Immunology, University Hospital Giessen and Marburg, Marburg, 35043, Germany (1)
Institute of Molecular Biology and Tumor Research (IMT)Philipps University of Marburg, Marburg, 35043, Germany and Department of Hematology, Oncology, and Immunology, University Hospital Giessen and Marburg, Marburg, 35043, Germany (1)
Karolinska Institute Division of Molecular Metabolism Department of Medical Biochemistry and Biophysics (1)
Turku Centre for Biotechnology (1)
Veterinary Centre for Resistance Research (TZR), Freie Universität Berlin, 14163 Berlin, Germany (1)

Location

United Kingdom (1)
France (1)
United States (1)

Keyword

Metastatic or unresectable locally advanced malignancies. (1)
Genomic alterations. (1)
Biological crizotinib targets (ALK, MET, ROS1, RON, AXL). (1)
CD161 (1)
Hormone receptor positive breast cancer (1)
Small bowel carcinoma (1)
Crizotinib (1)
Intestinal microbiota transplantation (1)

Previous page
1 / 148
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 148
Next page

Sort by:

Relevance

Page size

Chryseobacterium sediminis strain:IMT-174

Chryseobacterium sediminis strain:IMT-174 Genome sequencing and assembly

PRJNA560745 | ENA

SING IMT in pseudophakic eyes: Results of the first experiences.

Not available

S-EPMC11325279 | biostudies-literature

Topical Delivery of Protein and Peptide Using Novel Cell Penetrating Peptide IMT-P8.

Not available

S-EPMC4870705 | biostudies-literature

IMT-P8 potentiates Gram-positive specific antibiotics in intrinsically resistant Gram-negative bacteria.

Not available

S-EPMC11459922 | biostudies-literature

Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

This is a Phase 1/2a open-label, multicenter, dose escalation and dose expansion trial in which IMT-009 will be administered by the intravenous (IV) route to participants with solid tumors or lymphomas. The main goals of this study are to: * Find the recommended dose of IMT-009 that can be safely gi...

2750284 | ecrin-mdr-crc

Left versus right carotid artery IMT: differential impact of age, gender, and cardiovascular risk factors.

Not available

S-EPMC11561018 | biostudies-literature

Is inspiratory muscle training (IMT) an acceptable treatment option for people with chronic obstructive pulmonary disease (COPD) who have declined pulmonary rehabilitation (PR) and can IMT enhance PR uptake? A single-group prepost feasibility study in a home-based setting.

Not available

S-EPMC6701573 | biostudies-literature

Adherence to and impact of home-based high-intensity IMT in people with spinal cord injury: a pilot study.

Not available

S-EPMC9617741 | biostudies-literature

Proteomics of isolated rat manchettes

The manchette is a transient microtubular structure that plays a vital role in nuclear shaping during spermiogenesis. It comprises thousands of microtubules (MTs) that build a scaffold surrounding the distal half of the nucleus. The manchette distributes proteins and vesicles during spermiogenesis i...

ORGANISM(S): Rattus norvegicus (Rat)

2025-07-18 | PXD055902 | Pride

Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration.

Not available

S-EPMC4580609 | biostudies-literature

Previous page
1 / 148
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 148
Next page

Sort by:

Relevance

Page size

1479 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

First Public Date

Classification

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets